spacer
home > ebr > spring 2019 > the road to success
PUBLICATIONS
European Biopharmaceutical Review

The Road to Success

When thinking of biomarkers and their role in delivering personalised medicine, most will picture recent advances in oncology and, in particular, those that have arisen following seminal developments in human genomics, including the publishing of the human genome sequence in 1999. However, in reality, biomarkers have been around for much longer and have been driving a move to a more personalised approach to medicine for many years. This article examines both historical and modern groundbreaking examples to explain and exemplify the different types of biomarkers and their use in medicine.

Defining Biomarkers

There are many definitions of biomarkers, but this article will focus on one from a WHO collaborative study which defined a biomarker as “any substance, structure, or process that can be measured in the body or its products and influence or predict the incidence of outcome or disease” (1). If this definition is extended to include the effects of treatments, interventions, and exposure to environmental agents such as chemicals or nutrients, the possibilities are endless.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Karen Hills is Director of Marketing and Medical Affairs at PredictImmune, focussing on the launch of new products and clinical studies. Her background includes medical and marketing roles in both startup companies and Big Pharma. Karen has a PhD from the University of Cambridge and an Executive MBA from London Business School, UK.

Professor Ken Smith is Professor of Medicine and Head of the Department of Medicine at the University of Cambridge and is Chief Medical Officer at PredictImmune. He trained in nephrology and clinical immunology and completed a PhD at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. His lab runs a translational programme in autoimmune disease (particularly IBD, vasculitis, and SLE) that has led to the discovery of a novel prognosis-predicting biomarker currently in clinical trials and the identification of genes and pathways involved in disease pathogenesis.
spacer
Dr Karen Hills
spacer
spacer
spacer
Professor Ken Smith
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing Signant Health [Formerly CRF Bracket] and the Industry’s Most Comprehensive Patient-Centric Suite for Clinical Research

Philadelphia and London – June 10, 2019: CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health (signanthealth.com). Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signant makes it easier to participate in – and sites and study teams to run – clinical trials. This intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable sponsors and CROs to extend the reach of drug development, expand patient opportunities and improve data quality.
More info >>

White Papers

Choosing the Right CMO for HPAPI Manufacturing

AMRI

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement